ATE534396T1 - Probiotische mikroorganismen zur verbesserung der muskulären funktion - Google Patents

Probiotische mikroorganismen zur verbesserung der muskulären funktion

Info

Publication number
ATE534396T1
ATE534396T1 AT03765107T AT03765107T ATE534396T1 AT E534396 T1 ATE534396 T1 AT E534396T1 AT 03765107 T AT03765107 T AT 03765107T AT 03765107 T AT03765107 T AT 03765107T AT E534396 T1 ATE534396 T1 AT E534396T1
Authority
AT
Austria
Prior art keywords
gut
probiotic microorganisms
muscular function
improve muscular
probiotics
Prior art date
Application number
AT03765107T
Other languages
English (en)
Inventor
Irene Corthesy-Theulaz
De Bercik Elena Verdu
Premysl Bercik
Stephen Collins
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=29797269&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE534396(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nestec Sa filed Critical Nestec Sa
Application granted granted Critical
Publication of ATE534396T1 publication Critical patent/ATE534396T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT03765107T 2002-07-23 2003-07-23 Probiotische mikroorganismen zur verbesserung der muskulären funktion ATE534396T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02078064A EP1384483A1 (de) 2002-07-23 2002-07-23 Probiotische Mikroorganismen zur Behandlung von Colon Irritabile durch die Verbesserung der neuromuskulären Darmfunktion
PCT/EP2003/008076 WO2004009103A1 (en) 2002-07-23 2003-07-23 Probiotics for gut neuromuscular functions

Publications (1)

Publication Number Publication Date
ATE534396T1 true ATE534396T1 (de) 2011-12-15

Family

ID=29797269

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03765107T ATE534396T1 (de) 2002-07-23 2003-07-23 Probiotische mikroorganismen zur verbesserung der muskulären funktion

Country Status (18)

Country Link
US (1) US8021656B2 (de)
EP (2) EP1384483A1 (de)
JP (1) JP2005538087A (de)
KR (1) KR20050025978A (de)
CN (1) CN100480370C (de)
AT (1) ATE534396T1 (de)
AU (1) AU2003250149B2 (de)
BR (1) BR0313185A (de)
CA (1) CA2493255A1 (de)
ES (1) ES2376664T3 (de)
IL (1) IL166442A0 (de)
MX (1) MXPA05000880A (de)
NO (1) NO20050896L (de)
NZ (1) NZ538335A (de)
PT (1) PT1531841E (de)
RU (2) RU2346036C2 (de)
WO (1) WO2004009103A1 (de)
ZA (1) ZA200501559B (de)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004204751A1 (en) * 2003-01-09 2004-07-29 The Trustees Of The University Of Pennsylvania Compositions, methods and kits for enhancing the immunogenicity of a bacterial vaccine vector
US7749509B2 (en) * 2003-08-29 2010-07-06 Cobb And Company, Llp Treatment of autism using probiotic composition
US8192733B2 (en) 2003-08-29 2012-06-05 Cobb & Associates Probiotic composition useful for dietary augmentation and/or combating disease states and adverse physiological conditions
US7759105B2 (en) * 2003-08-29 2010-07-20 Cobb & Company, Llp Probiotic composition useful for dietary augmentation and/or combating disease states and adverse physiological conditions
US7731976B2 (en) * 2003-08-29 2010-06-08 Cobb And Company, Llp Treatment of irritable bowel syndrome using probiotic composition
MY143693A (en) 2004-03-24 2011-06-30 Nestec Sa Shelf stable product wih living micro-organisms
PL2805625T5 (pl) * 2005-02-28 2023-03-13 N.V. Nutricia Kompozycja odżywcza z prebiotykami i probiotykami
EP1903894A1 (de) * 2005-07-20 2008-04-02 Unilever N.V. Essbares produkt mit gesundheitsförderndem schimmel und/oder hefen
US8246946B2 (en) * 2005-09-27 2012-08-21 Cobb & Associates Treatment of bipolar disorder utilizing anti-fungal compositions
AU2007216461B2 (en) 2006-02-15 2012-08-30 Société des Produits Nestlé S.A. Use of bifidobacterium longum for the prevention and treatment of inflammation
US9005682B2 (en) * 2006-03-07 2015-04-14 Nestec S.A. Synbiotic mixture
AU2007267560B2 (en) * 2006-05-26 2010-10-21 Nestec S.A. Methods of use and nutritional compositions of Touchi Extract
CA2647161A1 (en) * 2006-05-28 2007-12-06 Cipla-Medpro (Pty) Ltd Probiotic strain and antimicrobial peptide derived therefrom
US7374924B2 (en) * 2006-06-05 2008-05-20 Biogaia Ab Use of selected lactic acid bacteria for reducing infantile colic
CN101998834B (zh) * 2007-10-11 2017-05-10 杜邦营养生物科学有限公司 用于缓解胃肠道病症相关症状的益生菌
PL2072053T3 (pl) * 2007-12-21 2013-02-28 Gervais Danone Sa Sposób zmniejszania obwodu brzucha przez podawanie bakterii bifidobacterium
US8825503B2 (en) * 2008-05-15 2014-09-02 Youdocs, Llc Methods and systems for improving human health using targeted probiotics
WO2010008272A1 (en) * 2008-07-15 2010-01-21 N.V. Nutricia Treatment of gut motility disorders
EP2216034A1 (de) * 2009-02-10 2010-08-11 Nestec S.A. Lactobacillus-helveticus-CNCM I-4095 und Gewichtskontrolle
WO2010103132A1 (es) * 2009-03-10 2010-09-16 Hero España, S.A. Aislamiento, identificación y caracterización de cepas con actividad probiótica a partir de heces de lactantes alimentados exclusivamente con leche materna
EP2251020A1 (de) * 2009-05-11 2010-11-17 Nestec S.A. Kurzzeitige Hochtemperaturbehandlung erzeugt mikrobielle Zubereitungen mit entzündungshemmenden Profilen
US8784798B2 (en) * 2009-05-11 2014-07-22 Nestec S.A. Bifidobacterium longum NCC2705 (CNCM I-2618) and immune disorders
EP2289527B1 (de) 2009-08-25 2018-02-21 Nestec S.A. Bifidobacterium longum und funktionelle GI-Erkrankungen
WO2011092261A1 (en) * 2010-01-28 2011-08-04 Ab-Biotics S.A. Probiotic composition for use in the treatment of bowel inflammation
BR112013002854B1 (pt) 2010-08-10 2023-03-07 Chr. Hansen A/S Uso de uma composição nematocida compreendendo bacillus subtilis e bacillus licheniformis, e processos para controle e/ou combate de fitonematoides, e para conferir resistência
EP2455094A1 (de) * 2010-11-11 2012-05-23 Nestec S.A. Nicht replizierende probiotische Mikroorganismen als Schutz vor Magen-Darm-Infektionen bei Kindern
JP5681533B2 (ja) * 2011-03-14 2015-03-11 ビオフェルミン製薬株式会社 消化管痛の予防又は軽減剤
US9579353B2 (en) * 2011-06-10 2017-02-28 Prothera, Inc. Pharmaceutical compositions containing pediococcus and methods for reducing the symptoms of gastroenterological syndromes
US20130045185A1 (en) * 2011-08-18 2013-02-21 Dupont Nutrition Biosciences Aps Strains and methods useful for mycotoxins
EP2609813A1 (de) * 2011-12-30 2013-07-03 Nestec S.A. Lactobacillus reuteri DSM 17938 zur Entwicklung des enterischen Nervensystems
US20130251829A1 (en) 2012-03-23 2013-09-26 Mead Johnson Nutrition Company Probiotic derived non-viable material for infection prevention and treatment
UA118339C2 (uk) * 2012-09-03 2019-01-10 Біогайа Аб Бактеріальний штам lactobacillus gasseri для лікування порушення моторики кишечнику (варіанти)
WO2014046804A1 (en) * 2012-09-20 2014-03-27 Prothera, Inc. Probiotic compositions and methods for the treatment of obesity and obesity-related conditions
US20150284675A1 (en) * 2012-10-25 2015-10-08 Compagnie Gervais Danone Streptococcus thermophilus strains for treating helicobacter pylori infection
WO2014096901A1 (en) * 2012-12-18 2014-06-26 Compagnie Gervais Danone Strain of bifidobacterium animalis ssp. animalis
US11179427B2 (en) 2013-01-21 2021-11-23 Eth Zurich Baby food composition comprising viable propionic acid-producing bacteria
TR201815566T4 (tr) 2013-06-03 2018-11-21 Proprev Ab Prevotella'dan en az bir bakteri suşu kullanarak obezite, metabolik sendrom, tip 2 diyabet, kardiyovasküler hastalıklar, demans, alzheimer hastalığı ve enflamatuvar bağırsak hastalığının tedavisi.
BR112016002650A2 (pt) * 2013-08-09 2017-09-12 Ab Biotics Sa probiótico para choro excessivo infantil
CN103497988B (zh) * 2013-09-23 2014-10-29 广州康代生物科技有限公司 一种安全高效乳酸菌产品的发酵生产方法
WO2016183535A1 (en) 2015-05-14 2016-11-17 University Of Puerto Rico Methods for restoring microbiota of newborns
RU2608871C1 (ru) * 2015-11-06 2017-01-25 Федеральное государственное бюджетное образовательное учреждение высшего образования "Вятский государственный университет" Штамм бактерий Lactobacillus paracasei 1, используемый для приготовления пробиотического препарата
WO2017117142A1 (en) 2015-12-28 2017-07-06 New York University Device and method of restoring microbiota of newborns
CN105767507B (zh) * 2016-03-30 2020-12-01 遂平广源饲料科技有限公司 一种饲料用微生态制剂、无抗饲料及其制备方法
KR101765559B1 (ko) 2016-09-27 2017-08-07 이대희 노루궁뎅이버섯을 포함하는 프로바이오틱스 조성물
AU2019404345B2 (en) * 2018-12-21 2026-04-16 Behnam ABBASIAN Compositions and methods for preventing or treating incontinence, overactive bladder, or menstrual cramping

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6861053B1 (en) * 1999-08-11 2005-03-01 Cedars-Sinai Medical Center Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth
US6562629B1 (en) * 1999-08-11 2003-05-13 Cedars-Sinai Medical Center Method of diagnosing irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth by detecting the presence of anti-saccharomyces cerivisiae antibodies (asca) in human serum
FI104465B (fi) * 1995-06-14 2000-02-15 Valio Oy Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö
CN1099289C (zh) * 1997-08-01 2003-01-22 北京东方百信生物技术有限公司 改善肠道生态平衡的微生物制剂及其工艺
WO1999017788A1 (en) * 1997-10-06 1999-04-15 Abbott Laboratories Composition of treatment of candidiasis
EP1034788A1 (de) * 1999-03-11 2000-09-13 Société des Produits Nestlé S.A. Milchsäure Bakterienstämme zur Verhinderung von Diarrhöe
EP1034787A1 (de) * 1999-03-11 2000-09-13 Société des Produits Nestlé S.A. Lactobacillus Stämme die gegen pathogenische Bacteria veranlassende Diarrhöe schutzen
RO121700B1 (ro) * 1999-03-11 2008-02-28 Societe Des Produits Nestle S.A. Bacterii lactobacillus capabile să prevină diareea cauzată de bacterii patogene şi rotavirusuri
ATE425244T1 (de) * 1999-08-05 2009-03-15 Nestle Sa Bifidobacteria zum vorbeugen von diarrhöe infolge pathogener bakterien
EP1251747B1 (de) * 2000-01-18 2012-01-25 Société des Produits Nestlé S.A. Haustierfutterzusammensetzung zur behandlung der helicobacter spezies in haustieren
ATE348626T1 (de) * 2000-03-24 2007-01-15 Nestle Sa Milchsäurebakterium zur prävention der bauchfellentzündung
WO2001097821A1 (en) 2000-06-19 2001-12-27 Mucoprotec Pty Ltd Immunotherapy or treating bacterial or viral infection at mucosal surfaces with probiotics, and compositions therefor.
IT1320772B1 (it) * 2000-11-02 2003-12-10 Proge Farm Srl Composizione farmaceutica a base di agenti attivi contro la candidaper il trattamento di disturbi della mucosa orale e intestinale
ES2323450T3 (es) * 2001-02-19 2009-07-16 Societe Des Produits Nestle S.A. Producto consumible que contiene probioticos.
US20030092163A1 (en) * 2001-07-26 2003-05-15 Collins John Kevin Probiotic bifidobacterium strains
PE20030283A1 (es) * 2001-07-26 2003-05-01 Alimentary Health Ltd Cepas de lactobacillus casei
US20040208863A1 (en) * 2003-01-30 2004-10-21 James Versalovic Anti-inflammatory activity from lactic acid bacteria

Also Published As

Publication number Publication date
AU2003250149A1 (en) 2004-02-09
NZ538335A (en) 2007-04-27
CN1678329A (zh) 2005-10-05
NO20050896L (no) 2005-04-18
ZA200501559B (en) 2006-05-31
RU2008132327A (ru) 2010-02-10
RU2005104950A (ru) 2005-12-10
CA2493255A1 (en) 2004-01-29
IL166442A0 (en) 2006-01-15
US8021656B2 (en) 2011-09-20
JP2005538087A (ja) 2005-12-15
KR20050025978A (ko) 2005-03-14
EP1384483A1 (de) 2004-01-28
ES2376664T3 (es) 2012-03-15
EP1531841A1 (de) 2005-05-25
CN100480370C (zh) 2009-04-22
EP1531841B1 (de) 2011-11-23
PT1531841E (pt) 2012-02-01
RU2490325C2 (ru) 2013-08-20
MXPA05000880A (es) 2006-01-24
AU2003250149B2 (en) 2009-01-22
RU2346036C2 (ru) 2009-02-10
BR0313185A (pt) 2005-06-21
US20070128178A1 (en) 2007-06-07
WO2004009103A1 (en) 2004-01-29

Similar Documents

Publication Publication Date Title
IL166442A0 (en) Probiotics for gut neuromuscular functions
ATE485827T1 (de) Ernährungszusammensetzung
DE60139554D1 (de) Probiotika zur primären prävention atopischer erkrankungen
ATE302265T1 (de) Einen lactobacillus-stamm enthaltende zusammensetzung und verwendungen davon
NZ599302A (en) Preventing diseases in infants delivered via caesarean section
IL144184A0 (en) Use of lactobacillus salivarius
BR9916062A (pt) Administração oral de lactobacillus para o tratamento e prevenção de infecção urogenital
EP1498039A4 (de) Lebende zellpräparate, die milchsäurebakterium als wirkstoff enthalten, sowie milchsäurebakteriumhaltige nahrungsmittel
ATE354964T1 (de) Probiotische zusammensetzung mit mindestens zwei milchsäurebakterienstämmen, die zur kolonisierung des magen-darm-trakts fähig sind und in kombination damit die eigenschaften, im darm zu überleben, an den darm zu binden, gegen infektion zu schützen und ballaststoffe zu fermentieren, aufweisen
DK1643861T3 (da) Fiber- og kalorierig flydende næringssammensætning til tarmsundhed hos ældre patienter
MXPA04005346A (es) Uso de microorganismos para una distribucion dirigida de sustancias a partes especificas del intestino.
EE200300220A (et) Bifidobacterium'i perekonna probiootiliste tüvedeskriinimise meetod
PL1793859T3 (pl) Leczenie zapalenia śluzówki jamy ustnej i jelit przez podawanie ludzkiej IL-18
SI1853308T1 (sl) Farmacevtski pripravek za zdravljenje rib ki se ga lahko administrira oralno postopek priprave navedenega pripravka in uporaba le tega
CN107683999A (zh) 有利于口腔健康的益生菌固体饮料
CN118924797A (zh) 一种含改善口腔与肠道菌群的益生菌的组合物和口腔微泡腾片及其应用
RU2002129937A (ru) Штамм бактерий bacillus subtilis, используемый для получения пробиотического препарата, предназначенного для профилактики и лечения желудочно-кишечных заболеваний сельскохозяйственных животных, птицы и рыбы
KR20040038401A (ko) 구내 종양 예방 및 조직 재생 분말
MD20010076A (ro) Preparat microbian sanogenic pentru asanarea tubului digestiv şi tratamentul disbacteriozei
ES2155782A1 (es) Utilizacion de bacterias acidolacticas pra preparar leches fermentadas para el tratamiento de niveles de actividad inmunitaria transitoriamente reducidos.
ES2155783A1 (es) Nueva utilizacion de lactobacillus casei para la preparacion de leches fermentadas para el tratamiento de niveles inmunitarios deprimidos.